Regulus Therapeutics Inc (RGLS)
2.68
+0.18
(+7.20%)
USD |
NASDAQ |
May 02, 16:00
2.68
0.00 (0.00%)
After-Hours: 17:49
Regulus Therapeutics Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.003M |
| March 31, 2023 | 0.004M |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.008M |
| December 31, 2021 | |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.194M |
| March 31, 2021 | 0.072M |
| December 31, 2020 | 0.503M |
| September 30, 2020 | 4.00M |
| June 30, 2020 | 0.674M |
| March 31, 2020 | 0.676M |
| December 31, 2019 | 1.141M |
| September 30, 2019 | 0.699M |
| June 30, 2019 | 0.331M |
| March 31, 2019 | 2.792M |
| December 31, 2018 | 0.026M |
| September 30, 2018 | 0.013M |
| June 30, 2018 | 0.184M |
| Date | Value |
|---|---|
| March 31, 2018 | 0.188M |
| December 31, 2017 | 0.373M |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | 0.14M |
| December 31, 2013 | 0.079M |
| September 30, 2013 | 0.095M |
| June 30, 2013 | 2.538M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2021
4.00M
Maximum
Sep 2020
0.5932M
Average
0.2625M
Median
Accounts Receivable (Quarterly) Benchmarks
| ACADIA Pharmaceuticals Inc | 98.27M |
| ADMA Biologics Inc | 27.42M |
| FibroGen Inc | 12.55M |
| Protara Therapeutics Inc | -- |
| Amylyx Pharmaceuticals Inc | 40.05M |